Continuous glucose monitoring is particularly useful on drinking occasions
Based on publicly available information, those states are: Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, and Wisconsin
Researchers reviewing Retatrutide side effects should look beyond headline results and consider the details of the study, including: participant population dose groups escalation schedule trial duration safety monitoring methods adverse event reporting discontinuation data comparison with placebo or active comparators Dose-related adverse events should never be translated into personal-use decisions
Shi B, Li H, He X